BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help
Search Results
Documents 1-3 out of 3 found
  Current Search:  marinol: 3     
HTML
100%
This Just Makes Me Sick!
Motley Fool Stock Advisor Since 2002, David and Tom Gardner have returned 27.99% while the S&P 500 returned -11.19%.

Try Stock Advisor free for 30 days.

GlaxoSmithKline's (NYSE: GSK) press release yesterday was enough to make me...

Motley Fool via MSN Money:  Jun 24 2009 8:37PM
Matching: marinol 		Find similar documents
HTML
100%
This Just Makes Me Sick!
Motley Fool Stock Advisor Since 2002, David and Tom Gardner have returned 28.44% while the S&P 500 returned -10.95%.

Try Stock Advisor free for 30 days.

GlaxoSmithKline's (NYSE: GSK) press release yesterday was enough to make me...

Motley Fool:  Jun 24 2009 8:26PM
Matching: marinol 		Find similar documents
HTML
100%
FDA rejects GlaxoSmithKline nausea, vomiting drug
FDA rejects GlaxoSmithKline experimental drug for nausea, vomiting; company plans next steps Buzz up!

Companies: TRENTON, N.J!

(AP) -- The U.S.

Food and Drug Administration has rejected GlaxoSmithKline PLC's application to approve an...

AP via Yahoo!:  Jun 23 2009 6:41PM
Matching: marinol 		Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.